DE3033897A1 - 5' -primaeraminoniedrigalkyl-4', 4-dinidrigalkylpsoralene und verfahren zu ihrer herstellung - Google Patents

5' -primaeraminoniedrigalkyl-4', 4-dinidrigalkylpsoralene und verfahren zu ihrer herstellung

Info

Publication number
DE3033897A1
DE3033897A1 DE19803033897 DE3033897A DE3033897A1 DE 3033897 A1 DE3033897 A1 DE 3033897A1 DE 19803033897 DE19803033897 DE 19803033897 DE 3033897 A DE3033897 A DE 3033897A DE 3033897 A1 DE3033897 A1 DE 3033897A1
Authority
DE
Germany
Prior art keywords
lower alkyl
aminomethyl
dimethylpsoralen
psoralen
munich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803033897
Other languages
German (de)
English (en)
Other versions
DE3033897C2 (US08124317-20120228-C00026.png
Inventor
Kurt Dunn Kalamazoo Mich. Kaufman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELDER PHARMACEUTICALS Inc COSTA MESA CALIF US
Original Assignee
Thomas C Elder Inc 47842 Hamilton Ind
Elder Thomas C Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas C Elder Inc 47842 Hamilton Ind, Elder Thomas C Inc filed Critical Thomas C Elder Inc 47842 Hamilton Ind
Publication of DE3033897A1 publication Critical patent/DE3033897A1/de
Application granted granted Critical
Publication of DE3033897C2 publication Critical patent/DE3033897C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19803033897 1979-09-10 1980-09-09 5' -primaeraminoniedrigalkyl-4', 4-dinidrigalkylpsoralene und verfahren zu ihrer herstellung Granted DE3033897A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/073,908 US4298614A (en) 1979-09-10 1979-09-10 5'-Aminoalkyl-4',4-dialkylpsoralens

Publications (2)

Publication Number Publication Date
DE3033897A1 true DE3033897A1 (de) 1981-04-02
DE3033897C2 DE3033897C2 (US08124317-20120228-C00026.png) 1989-04-13

Family

ID=22116517

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803033897 Granted DE3033897A1 (de) 1979-09-10 1980-09-09 5' -primaeraminoniedrigalkyl-4', 4-dinidrigalkylpsoralene und verfahren zu ihrer herstellung

Country Status (6)

Country Link
US (1) US4298614A (US08124317-20120228-C00026.png)
JP (1) JPS5645478A (US08124317-20120228-C00026.png)
CA (1) CA1141767A (US08124317-20120228-C00026.png)
DE (1) DE3033897A1 (US08124317-20120228-C00026.png)
FR (1) FR2464958A1 (US08124317-20120228-C00026.png)
GB (2) GB2058766B (US08124317-20120228-C00026.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294822A (en) * 1980-07-29 1981-10-13 Thomas C. Elder, Inc. 5-Aminoalkyl-4,4,8-trialkylpsoralens
JPS61112466A (ja) * 1984-11-07 1986-05-30 Hitachi Ltd 局線中継台併合方法
US5593823A (en) * 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US5871900A (en) * 1993-06-28 1999-02-16 Cerus Corporation Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
US6004741A (en) * 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US6004742A (en) * 1993-06-28 1999-12-21 Cerus Corporation Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
US20020115585A1 (en) * 1996-06-07 2002-08-22 Hei Derek J. Method and devices for the removal of psoralens from blood products
CA2300382C (en) 1997-11-20 2004-04-20 Cerus Corporation New psoralens for pathogen inactivation
EP3157519B1 (en) * 2014-06-19 2021-05-12 Immunolight, LLC Methods and systems for treating cell proliferation disorders with psoralen derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746942A1 (de) * 1976-10-20 1978-04-27 Univ California Neue psoralenderivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130568A (en) * 1976-09-14 1978-12-19 Hoffmann-La Roche Inc. 8-Methoxypsoralen derivatives
US4169204A (en) * 1976-10-20 1979-09-25 Regents Of The University Of California Psoralens
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2746942A1 (de) * 1976-10-20 1978-04-27 Univ California Neue psoralenderivate

Also Published As

Publication number Publication date
CA1141767A (en) 1983-02-22
GB2058766B (en) 1983-06-08
US4298614A (en) 1981-11-03
FR2464958A1 (fr) 1981-03-20
GB2100267B (en) 1983-10-05
JPS5645478A (en) 1981-04-25
DE3033897C2 (US08124317-20120228-C00026.png) 1989-04-13
GB2100267A (en) 1982-12-22
FR2464958B1 (US08124317-20120228-C00026.png) 1983-07-08
GB2058766A (en) 1981-04-15

Similar Documents

Publication Publication Date Title
DE3031164C2 (de) Angelicine enthaltende Arzneimittel, Angelicine als solche sowie Verfahren zu deren Herstellung
DE2858042C2 (de) Rechtsdrehendes Isomer eines asymmetrischen Spirohydantoins sowie der Basensalze hiervon und ihre Verwendung
DE3033897C2 (US08124317-20120228-C00026.png)
DE3129750A1 (de) 5'-aminoalkyl-4',4,8-trialkylpsoralene
DE1645971C3 (de) (lndazol-3-yl)-oxyessigsäurederivate, Verfahren zu ihrer Herstellung und Mittel mit entzündungshemmender Wirkung
DE2901477A1 (de) Thienohydantoinderivate und diese enthaltende arzneimittel
DE3033895C2 (US08124317-20120228-C00026.png)
DE3033896C2 (US08124317-20120228-C00026.png)
DD201903A5 (de) Verfahren zur herstellung von derivaten des thienopyridonons
DE2301541A1 (de) 1-(2-substituierte chromonyloxy)-2hydroxy-3-(substituierte phenoxy)propane
DE2007345A1 (de) Neue substituierte Hexahydroimidazochinoline und deren Säureanlagerungssalze
DE2253914C3 (de) Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel
DE3438244C2 (US08124317-20120228-C00026.png)
DE3337207C2 (US08124317-20120228-C00026.png)
DE2502504C3 (de) Phenothiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CH644596A5 (de) 2,6-dimethyl-1,4-dihydropyridin-3,5-dikarbonsaeureester und verfahren zu ihrer herstellung.
DE2618223C2 (US08124317-20120228-C00026.png)
DE2329745A1 (de) Therapeutisches mittel und verwendung desselben
DE1595870C3 (de) Verfahren zur Herstellung von 3-(o-Methoxyphenoxy)-1,2-propandiolnicotinaten und deren Säureadditionssalzen
DE2109602C3 (de) Alkali-epicatechin-2-sulfonate und Verfahren zur Herstellung von Epicatechin-2-sulfonsäuren und von deren Alkali-, Calcium-, Magnesium-, oder Ammoniumsalzen
DE2639671A1 (de) Chromenverbindungen, verfahren zu deren herstellung sowie dieselben enthaltende, als antijuvenilhormon wirkende insektizide
DE2343291A1 (de) 2-carboxy-4-oxo-4h,10h-(2)-benzopyranoeckige klammer auf 4,3-g eckige klammer zu -(1)-benzopyrane und ihre salze
CH649536A5 (de) Wasserloesliche derivate von 6,6'-methylen-bis(2,2,4-trimethyl-1,2-dihydrochinolin) und verfahren zur herstellung derselben.
DE2000636C3 (de) Cyclopropancarbonsäureester, Verfahren zu deren Herstellung und insektizide Zubereitungen
AT218017B (de) Verfahren zur Herstellung von Ketonen des 4-Hydroxy-cumarins

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: ELDER PHARMACEUTICALS INC., BRYAN, OHIO, US

8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

8127 New person/name/address of the applicant

Owner name: ELDER PHARMACEUTICALS INC., COSTA MESA, CALIF., US

8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee